Publications et communications

 

PRINCIPALES PUBLICATIONS DES DERNIÈRES ANNÉES

 

2017

Renaud F, Bibeau F, Leteurtre E, Delaeter C, Dib M, Harter V, Adenis A, Piessen G, Mariette C; FREGAT working group. FREGAT: French clinico-biological database dedicated to esogastric cancers. Ann Pathol. 2017 Dec;37(6):457-466.

 

Davy G, Rousselin A, Goardon N, Castéra L, Harter V, Legros A, Muller E, Fouillet R, Brault B, Smirnova AS, Lemoine F, de la Grange P, Guillaud-Bataille M, Caux-Moncoutier V, Houdayer C, Bonnet F, Blanc-Fournier C, Gaildrat P, Frebourg T, Martins A, Vaur D, Krieger S. Detecting splicing patterns in genes involved in hereditary breast and ovarian cancer. Eur J Hum Genet. 2017 Oct;25(10):1147-1154.

 

Thomas J, Fermé C, Noordijk EM, Morschhauser F, Girinsky T, Gaillard I, Lugtenburg PJ, André M, Lybeert MLM, Stamatoullas A, Beijert M, Hélias P, Eghbali H, Gabarre J, van der Maazen RWM, Jaubert J, Bouabdallah K, Boulat O, Roesink JM, Christian B, Ong F, Bordessoule D, Tertian G, Gonzalez H, Vranovsky A, Quittet P, Tirelli U, de Jong D, Audouin J, Aleman BMP, Henry-Amar M. Comparison of 36 Gy, 20 Gy, or No Radiation Therapy After 6 Cycles of EBVP Chemotherapy and Complete Remission in Early-Stage Hodgkin Lymphoma Without Risk Factors: Results of the EORT-GELA H9-F Intergroup Randomized Trial. Int J Radiat Oncol Biol Phys. 2017 Oct 27. pii: S0360-3016(17)33984-6.

 

Eichenauer DA, Becker I, Monsef I, Chadwick N, de Sanctis V, Federico M, Fortpied C, Gianni AM, Henry-Amar M, Hoskin P, Johnson P, Luminari S, Bellei M, Pulsoni A, Sydes MR, Valagussa P, Viviani S, Engert A, Franklin J. Secondary malignant neoplasms, progression-free survival and overall survival in patients treated for Hodgkin lymphoma: a systematic review and meta-analysis of randomized clinical trials. Haematologica. 2017 Oct;102(10):1748-1757.

 

Petry S, Sévin C, Fleury MA, Duquesne F, Foucher N, Laugier C, Henry-Amar M, Tapprest J. Differential distribution of vapA-positive Rhodococcus equi in affected and unaffected horse-breeding farms. Vet Rec. 2017 Aug 5;181(6):145.

 

Fermé C, Thomas J, Brice P, Casasnovas O, Vranovsky A, Bologna S, Lugtenburg PJ, Bouabdallah R, Carde P, Sebban C, Eghbali H, Salles G, van Imhoff GW, Thyss A, Noordijk EM, Reman O, Lybeert MLM, Janvier M, Spina M, Audhuy B, Raemaekers JMM, Delarue R, Anglaret B, de Weerdt O, Marjanovic Z, Tersteeg RJHA, de Jong D, Brière J, Henry-Amar M; European Organisation for Research and Treatment of Cancer Lymphoma Group, and; Groupe d'Étude des Lymphomes de l'Adulte. ABVD or BEACOPPbaseline along with involved-field radiotherapy in early-stage Hodgkin Lymphoma with risk factors: Results of the European Organisation for Research and Treatment of Cancer (EORTC)-Groupe d'Étude des Lymphomes de l'Adulte (GELA) H9-U intergroup randomised trial. Eur J Cancer. 2017 Aug;81:45-55.

 

Anthony S, Hebel P, Garrel A, Oliveri V, Thieblemont C, Ribrag V, Tilly H, Haioun C, Casasnovas RO, Morschhauser F, Feugier P, Delarue R, Ysebaert L, Sebban C, Broussais F, Damaj G, Nerich V, Jais JP, Salles G, Henry-Amar M, Mounier N. Conduct of epidemiologic studies in French cancer survivors: Methods, difficulties encountered and solutions provided. Lessons learned from the SIMONAL study on long-term toxicities after non-Hodgkin lymphoma treatment Bull Cancer. 2017 Mar;104(3):221-231

 

2016

Henry-Amar M, Busson R. Does persistent fatigue in survivors relate to cancer? Lancet Oncol. 2016 Oct;17(10):1351-1352

 

Debeaumont D, Tardif C, Folope V, Castres I, Lemaitre F, Tourny C, Dechelotte P, Thill C, Darmon A, Coquart JB. A specific prediction equation is necessary to estimate peak oxygen uptake in obese patients with metabolic syndromeJ Endocrinol Invest2016 Jun;39(6):635-42

 

Oldrini G, Harter V, Witte Y, Martrille L, Blum A. Age Estimation in Living Adults using 3D Volume Rendered CT Images of the Sternal Plastron and Lower ChestJournal of Forensic Sciences2016 Jan;61(1):127-33

 

2015

Maraldo MV, Giusti F, Vogelius IR, Lundemann M, van der Kaaij MA, Ramadan S, Meulemans B, Henry-Amar M, Aleman BM, Raemaekers J, Meijnders P, Moser EC, Kluin-Nelemans HC, Feugier P, Casasnovas O, Fortpied C, Specht L; European Organisation for Research and Treatment of Cancer (EORTC) Lymphoma Group. Cardiovascular disease after treatment for Hodgkin's lymphoma: an analysis of nine collaborative EORTC-LYSA trials. Lancet Haematol. 2015 Nov;2(11):e492-502

 

Durand I, Deverriere G, Thill C, Lety AS, Parrod C, David N, Barre E, Hazelzet T. Prenatal Detection of Coarctation of the Aorta in a Non-selected Population: A Prospective Analysis of 10 Years of Experience. Pediatr Cardiol. 2015 Aug;36(6):1248-54

 

Loschi M, Thill C, Gray C, David M, Bagatha MF, Chamseddine A, Contentin N, Jardin F, Lanic H, Lemasle E, Lenain P, Stamatoullas A, Tilly H, Lepretre S. Invasive Aspergillosis in Neutropenic Patients During Hospital Renovation: Effectiveness of Mechanical Preventive Measures in a Prospective Cohort of 438 PatientsMycopathologia. 2015 Jun;179(5-6):337-45

 

Yaribakht S, Guillemin F, Harter V, Malartic C, Marchal F. New approach of learning curve for robotic-assisted gynecologic oncology surgery. Gynecol Obstet Fertil. 2015 May;43(5):348-55

 

Raft J, Guerci P, Harter V, Fuchs-Buder T, Meistelman C. Biological evaluation of the effect of sugammadex on hemostasis and bleeding. Korean J Anesthesiol. 2015 Feb;68(1):17-21

 

2014

Boyrie S, Charra-Brunaud C, Harter V, Ducassou A, Kirova Y, Barillot I, Krzisch C, Lang P, Baron MH, Montbarbon X, Delannes M, Peiffert D. Impact of dosimetric parameters on local control for patients treated with three-dimensional pulsed dose-rate brachytherapy for cervical cancer. Brachytherapy. 2014 Jul-Aug;13(4):326-31

 

Petry S, Sévin C, Fleury MA, Duquesne F, Foucher N, Laugier C, Henry-Amar M, Tapprest J. Distribution of virulent Rhodococcus equi and its virulence plasmid types in environment from horse-breeding farms with and without a history of R. equi pneumonia in Normandy (France). Res Vet Sc. 2014 (short communication, in press)

 

Haddad A, Peiffert D, Lapeyre M, Harter V, Buchheit I, Graff P. A case-control study of patients with squamous cell carcinoma of the oral cavity and oropharynx treated with pulsed-dose-rate brachytherapy. Brachytherapy. 2014 Jun 6. pii: S1538-4721(14)00538-8

 

Renoult F, Marchal C, Brunaud C, Harter V, Peiffert D. Safety and efficacy of whole breast irradiation with a concomitant boost: Analysis of 121 cases treated at the institut de cancérologie de Lorraine. Cancer Radiother. 2014 Jun;18(3):165-70

 

Huger S, Graff P, Harter V, Marchesi V, Royer P, Diaz JC, Aouadi S, Wolf D, Peiffert D, Noel A. Evaluation of the Block Matching deformable registration algorithm in the field of head-and-neck adaptive radiotherapy. Phys Med. 2014 May;30(3):301-8

 

Rebstock LE, Leufflen L, Leroux A, Harter V, Verhaeghe JL, Marchal F. Granulosa cell tumor of the ovary: Retrospective study of 17 cases. Gynecol Obstet Fertil. 2014 May;42(5):331-3

 

van der Kaaij MA, van Echten-Arends J, Heutte N, Meijnders P, Abeilard-Lemoisson E, Spina M, Moser EC, Allgeier A, Meulemans B, Lugtenburg PJ, Aleman BM, Noordijk EM, Fermé C, Thomas J, Stamatoullas A, Fruchart C, Eghbali H, Brice P, Smit WG, Sebban C, Doorduijn JK, Roesink JM, Gaillard I, Coiffier B, Lybeert ML, Casasnovas O, André M, Raemaekers JM, Henry-Amar M, Kluin-Nelemans JC; for the European Organisation for Research and Treatment of Cancer Lymphoma Group and the Groupe d’Étude des Lymphomes de l'Adulte. Cryopreservation, semen use and the likelihood of fatherhood in male Hodgkin lymphoma survivors: an EORTC-GELA Lymphoma Group cohort study. Hum Reprod. 2014 Mar;29(3):525-33

 

2013

Mauguen A, Pignon JP, Burdett S, Domerg C, Fisher D, Paulus R, Mandrekar SJ, Belani CP, Shepherd FA, Eisen T, Pang H, Collette L, Sause WT, Dahlberg SE, Crawford J, O'Brien M, Schild SE, Parmar M, Tierney JF, Le Pechoux C, Michiels S; Surrogate Lung Project Collaborative Group : […] Henry-Amar M […]. Surrogate endpoints for overall survival in chemotherapy and radiotherapy trials in operable and locally advanced lung cancer: a re-analysis of meta-analyses of individual patients' data. Lancet Oncol. 2013 Jun;14(7):619-26

 

Harlé A, Busser B, Rouyer M, Harter V, Genin P, Leroux A, Merlin JL. Comparison of COBAS 4800 KRAS, TaqMan PCR and high resolution melting PCR assays for the detection of KRAS somatic mutations in formalin-fixed paraffin embedded colorectal carcinomas. Virchows Arch. 2013 Mar;462(3):329-35

 

Harlé A, Lion M, Lozano N, Husson M, Harter V, Genin P, Merlin JL. Analysis of PIK3CA exon 9 and 20 mutations in breast cancers using PCR-HRM and PCR-ARMS: correlation with clinicopathological criteria. Oncol Rep. 2013 Mar;29(3):1043-52

 

Chretien AS, Harlé A, Meyer-Lefebvre M, Rouyer M, Husson M, Ramacci C, Harter V, Genin P, Leroux A, Merlin JL. Optimization of routine KRAS mutation PCR-based testing procedure for rational individualized first-line-targeted therapy selection in metastatic colorectal cancer. Cancer Med. 2013 Feb;2(1):11-20

 

2012

Mallet E, Gaudelus J, Reinert P, Stagnara J, Bénichou J, Castanet M, Thill C, Basuyau JP, Billard C, Roden A, Uhlrich J. Prophylactic prescription of vitamin D in France: national multicenter epidemiological study of 3240 children under 6 years of age. Arch Pediatr. 2012 Dec;19(12):1293-302.

 

van der Kaaij MA, Heutte N, Meijnders P, Abeilard-Lemoisson E, Spina M, Moser LC, Allgeier A, Meulemans B, Dubois B, Simons AH, Lugtenburg PJ, Aleman BM, Noordijk EM, Fermé C, Thomas J, Stamatoullas A, Fruchart C, Brice P, Gaillard I, Doorduijn JK, Sebban C, Smit WG, Bologna S, Roesink JM, Ong F, André MP, Raemaekers JM, Henry-Amar M, Kluin-Nelemans HC. Parenthood in survivors of Hodgkin lymphoma: an EORTC-GELA general population case-control study. J Clin Oncol. 2012 Nov 1;30(31):3854-63

 

Charra-Brunaud C, Harter V, Delannes M, Haie-Meder C, Quetin P, Kerr C, Castelain B, Thomas L, Peiffert D. Impact of 3D image-based PDR brachytherapy on outcome of patients treated for cervix carcinoma in France: results of the French STIC prospective study. Radiother Oncol. 2012 Jun;103(3):305-13

 

Renard-Oldrini S, Brunaud C, Huger S, Marchesi V, Tournier-Rangeard L, Bouzid D, Harter V, Peiffert D. Dosimetric comparison between the intensity modulated radiotherapy with fixed field and Rapid Arc of cervix cancer. Cancer Radiother. 2012 May;16(3):209-14

 

van der Kaaij MAE, Heutte N, Meijnders P, Abeilard-Lemoisson E, Spina M, Moser EC, Allgeier A, Meulemans B, Simons AHM, Lugtenburg PJ, Aleman BMP, Noordijk EM, Fermé C, Thomas J, Stamatoullas A, Fruchart C, Brice P, Gaillard I, Bologna S, Ong F, Eghbali H, Doorduijn JK, Morschhauser F, Sebban C, Roesink JM, Bouteloup M, van Hoof A, Raemaekers JMM, Henry-Amar M, Kluin-Nelemans HC. Premature ovarian failure and fertility in long-term survivors of Hodgkin lymphoma: a European Organisation for Research and Treatment of Cancer Lymphoma Group and Groupe d’Étude des Lymphomes de l’Adulte cohort study. J Clin Oncol 2012;30:291-299.

 

2011

Noal S, Levy C, Hardouin A, Rieux C, Heutte N, Segura C, Collet F, Allouache D, Switsers O, Delcambre C, Delozier T, Henry-Amar M, Joly F. One-year longitudinal study of fatigue, cognitive functions, and quality of life after adjuvant radiotherapy for breast cancer. Int J Radiat Oncol Biol Phys 2011;81(3):795-803.

 

Klein D, Mercier M, Abeilard E, Puyraveau M, Danzon A, Dalstein V, Pozet A, Guizard AV, Henry-Amar M, Velten M. Long-term quality of life after breast cancer: a French registry-based controlled study. Breast Cancer Res Treat 2011;129(1):125-134.

 

Caravati-Jouvenceaux A, Launoy G, Klein D, Henry-Amar M, Abeilard E, Danzon A, Pozet A, Velten M, Mercier M. Health-related quality of life among long-term survivors of colorectal cancer: a population-based study. Oncologist 2011;16(11):1626-1636

 

Tapprest J, Laugier C, Sevin C, Foucher N, Duquesne F, Henry-Amar M. Pulmonary rhodococcosis in foals: risk factors related to horse husbandry in France. Revue Méd Vét 2011;162(12):563-573

 

Lheureux S, Clarisse B, Launay-Vacher V, Gunzer K, Delcambre-Lair C, Bouhier-Leporrier K, Kaluzinski L, Maron D, Ngo MD, Grossi S, Dubois B, Zalcman G, Joly F. Evaluation of current practice: management of chemotherapy-related toxicities. Anticancer Drugs 2011;22(9):919-925.

 

Clin B, Morlais F, Launoy G, Guizard AV, Dubois B, Bouvier V, Desoubeaux N, Marquignon MF, Raffaelli C, Paris C, Galateau-Salle F, Guittet L, Letourneux M. Cancer incidence within a cohort occupationally exposed to asbestos: a study of dose--response relationships. Occup Environ Med 2011;68(11):832-836.

 

2010

Joly F, Sevin E, Lortholary A, Priou F, Paitel JF, Fabbro M, Henry-Amar M, Hamond K, Bourgeois H. Association of pegylated liposomal doxorubicin and ifosfamide in early recurrent ovarian cancer patients: a multicenter phase II trial. Gynecol Oncol 2010;116(3):312-316

 

Fritschi L, Guenel P, Ahrens W; European Study Group on Occupational Causes of Rare Cancers. Breast cancer in priests: follow-up of an observation made 167 years ago. Eur J Epidemiol 2010;25(3):219-221

 

2009

Clin B, Morlais F, Dubois B, Guizard AV, Desoubeaux N, Marquignon MF, Raffaelli C, Paris C, Galateau-Salle F, Launoy G, Letourneux M. Occupational asbestos exposure and digestive cancers - a cohort study. Aliment Pharmacol Ther. 2009 Aug 15;30(4):364-74

 

Labiche A, Elie N, Herlin P, Denoux Y, Crouet H, Heutte N, Joly F, Héron JF, Gauduchon P, Henry-Amar M. Prognostic significance of tumour vascularisation on survival of patients with advanced ovarian carcinoma. Histol Histopathol 2009;24(4):425-435

 

Favier O, Heutte N, Stamatoullas-Bastard A, Carde P, Van't Veer MB, Aleman BM, Noordijk EM, Thomas J, Fermé C, Henry-Amar M; for the European Organization for Research and Treatment of Cancer (EORTC) Lymphoma Group and the Groupe d'Études des Lymphomes de l'Adulte (GELA). Survival after Hodgkin lymphoma: causes of death and excess mortality in patients treated in 8 consecutive trials. Cancer 2009;115(8):1680-1691

 

Aide N, Heutte N, Rame JP, Rousseau E, Henry-Amar M, Bardet S. Clinical relevance of single-photon emission computed tomography/computed tomography of the neck and thorax in postablation (131)I scintigraphy for thyroid cancer. J Clin Endocrinol Metabol 2009;94(6):2075-2784

 

Haas RL, Girinsky T, Aleman BM, Henry-Amar M, de Boer JP, de Jong D. Low-dose involved-field radiotherapy as alternative treatment of nodular lymphocyte predominance Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys 2009;74(4):1199-1202

 

Garsi JP, Schlumberger M, Ricard M, Labbé M, Ceccarelli C, Schvartz C, Henry-Amar M, Bardet S, Rubino C, de Vathaire. Health outcomes of children fathered by patients treated with radioiodine for thyroid cancer. Clin Endocrinol 2009;71(6):880-883

 

Joly F, Houédé N, Noal S, Chevreau C, Priou F, Chinet-Charrot P, Rolland F, Fléchon A, Henry-Amar M, Culine S. Do patients with advanced urothelial carcinoma benefit from weekly paclitaxel chemotherapy? A GETUG phase II study. Clin Genitourin Cancer 2009 Aug 1;7(2):E28-E33

 

Joly F, Petit T, Pautier P, Guardiola E, Mayer F, Chevalier-Place A, Delva R, Sevin E, Henry-Amar M, Bourgeois H. Weekly combination of topotecan and gemcitabine in early recurrent ovarian cancer patients: A French multicenter phase II study. Gynecol Oncol 2009;115(3):382-388

 

Heutte N, Flechtner HH, Mounier N, Mellink WAM, Meerwaldt JH, Eghbali H, van’t Veer MB, Noordijk EM, Kluin-Nelemans JC, Lampka E, Thomas J, Lugtenburg PJ, Viterbo L, Carde P, Hagenbeek A, van der Maazen RWM, Smit WGJM, Brice P, van Marwijk Kooy M, Baars JW, Poortmans P, Tirelli U, Leeksma OC, Tomšič R, Feugier P, Salles G, Gabarre J, Kersten MJ, van den Neste E, Creemers GJM, Gaillard I, Meijnders P, Tertian G, Reman O, Muller HP, Troncy J, Blanc M, Schroyens W, Voogt PJ, Wijermans P, Rieux C, Fermé C, Henry-Amar M, for the EORTC-GELA H8 Trial. Quality of life after successful treatment of early-stage Hodgkin lymphoma: 10-year follow-up of the EORTC-GELA H8 randomised controlled trial. Lancet Oncol 2009;10:1160-1170

 

van der Kaaij MA, Heutte N, van Echten-Arends J, Raemaekers JM, Carde P, Noordijk EM, Fermé C, Thomas J, Eghbali H, Brice P, Bonmati C, Henry-Amar M, Kluin-Nelemans HC. Sperm quality before treatment in patients with early stage Hodgkin’s lymphoma enrolled in EORTC-GELA Lymphoma Group trials. Haematologica 2009;94:1691-1697

 

2008

Béghin L, Castera M, Manios Y, Gilbert CC, Kersting M, De Henauw S, Kafatos A, Gottrand F, Molnar D, Sjöström M, Leclercq C, Widhalm K, Mesana MI, Moreno LA, Libersa C; HELENA Study Group. Quality assurance of ethical issues and regulatory aspects relating to good clinical practices in the HELENA Cross-Sectional Study. Int J Obes (Lond). 2008 Nov;32 Suppl 5:S12-8.

 

PRINCIPALES COMMUNICATIONS

 

Maraldo M, Giusti F, Vogelius I, Lundemann M, van der Kaaij M, Ramadan S, Meulemans B, Henry-Amar M, Aleman B, Raemaekers J, Meijnders P, Moser E, Kluin-Nelemans H, Feugier P, Casasnovas O, Fortpied C, Specht L. Cardiovascular disease after therapy for hodgkin lymphoma: a detailed analysis of 9 collaborative eortc-lysa trials. 13th International Conference on Malignant Lymphoma (13-ICML). June 17-20, 2015; Lugano, Switzerland. Hematol Oncol 2015;33:122 (Abstr 043) (communication orale).

 

Busson R, van der Kaaij M, Fermé C, Henry-Amar M. Prévalence de la fatigue chronique chez les patients guéris d’un lymphome de Hodgkin : suivi à long terme des essais conduits par l’EORTC et le GELA (1964-2004)GSO international workshop - Evaluation et analyse de la qualité de vie en oncologie, Montpellier, 2014 (communication affichée)

 

J. Jenvrin-Breton, M.C. Grach, S. Jeandel, A. Gueguen, O.Rigal, A. Bencheman, C. Lefeuvre, F. Lebrun, E. Fortin, S. Vilet, L. Rosaert, J.M. Commer, F. Maucourt, S. Benoit, P. Bourrel, N. Lemoal, N. Lelievre, M. Blondel, A. Barrault, M. Henry-Amar, M.Y. Moreau, J.M. Grellard, B. Griffon, B. Clarisse, C. Thill. Soins de bouche et cancer: Prise en charge des patients identifiés soins palliatifs et hospitalisés.  Congrès de la Société Française d’Accompagnement et de soins Palliatifs, Lille, 2013 (communication affichée)

 

Lange M, Giffard B, Noal S, Heutte N, Daireaux A, Rieux C, Lévy C, Allouache D, Jouie L, Dubois B, Le Fel J, Roy V, Rigal O, Kurtz E, Eustache F, Joly F. Fonctionnement cognitif de patientes âgées traitées pour un cancer du sein localisé : évaluation pré-traitement adjuvant. 6èmes journées scientifiques du Cancéropôle Nord-Ouest. Deauville, 2013 (communication affichée)

 

Harter V, Mayeux M, Desandes E. Identitovigilance et détection de doublons au Centre Alexis Vautrin (CLCC de la région Lorraine). Congrés EMOIS, Nancy, 2013 (communication orale)

 

Harter V, Peiffert D, Levitchi M, Charra-Brunaud C, Desandes E. Détermination d’une dose-seuil prédictive de l’apparition de toxicités digestives et urinaires à partir de la vraisemblance du modèle de Cox chez des patientes traitées par curiethérapie PDR 3D pour uncarcinome du col de l’utérus. 6ème Conférence Francophone d'Épidémiologie Clinique - 19èmes Journées des Statisticiens des Centres de Lutte contre le Cancer. Lyon, 2012 (communication affichée)

 

van der Kaaij MAE, Heutte N, Meijnders P, Raemaekers JMM, Abeilard-Lemoisson E, Allgeier A, Meulemans B, Simons AHM, Mounier N, Henry-Amar M, Kluin-Nelemans JC. Parenthood in survivors of Hodgkin lymphoma: An EORTC-GELA general population case-control study. ASCO Annual Meeting. June 3-7, 2011; Chicago, USA. J Clin Oncol 2011;29:15s (Suppl; Abstr 9062) (communication affichée).

 

Dubray B, Beckendorf V, Guerif S, Le Prise E, Reynaud-Bougnoux A, Hannoun Levi JM, Nguyen TD, Hennequin C, Cretin J, Fayolle-Campana M, Lagrange JL, Bachaud JM, Azria D, Grangirard A, Pommier P, Simon JM, Harter V, Habibian M. Does short-term androgen depletion add to high dose radiotherapy (80 Gy) in localized intermediate risk prostate cancer ? - Interim analysis of GETUG 14 randomized trial (EU-20503 / NCT00104741). ASCO Annual Meeting. June 3-7, 2011; Chicago, USA (communication affichée).

 

van der Kaaij MAE, Heutte N, Meijnders P, Raemaekers JMM, Abeilard-Lemoisson A, Allgeier A, Meulemans B, Simons AHM, Mounier N, Henry-Amar M, Kluin-Nelemans HC. Parenthood in survivors of Hodgkin lymphoma: an EORTC-GELA general population case-control study. 11th International Conference on Malignant Lymphoma (11-ICML). June 15-18, 2011; Lugano, Switzerland. Ann Oncol 2011;22(Suppl 4):iv139 (Abstr 165) (communication orale).

 

Dubois B, Laborde L. Role du datamanager dans le processus qualité. Eurocancer, John Libbey Eurotext, Paris, 2011, pp.299-300 (communication orale) 

 

OUVRAGES

 

Culine L, Belda-Mathieu E, Berneur-Morisseau C, Castéra-Tellier M, Demerville L. Mémento de la recherche biomédicale portant sur un médicament à usage humain. Springer Deuxième édition, 2011